Filgotinib shows improvements in rheumatoid arthritis trial - Drug Development Technology

Filgotinib shows improvements in rheumatoid arthritis trial  Drug Development Technology

An international Phase III trial has demonstrated that Gilead's filgotinib led to improvements in rheumatoid arthritis patients.



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases